Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» inflammatory disease
inflammatory disease
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Benzinga
Thu, 09/21/23 - 11:55 am
Inmagene
Aditum Bio
Celexor
autoimmune disease
inflammatory disease
Gilead, Tentarix collab to develop cancer, inflammatory disease therapies
Medical Marketing and Media
Wed, 08/16/23 - 10:17 am
Gilead Sciences
Tentarix Biotherapeutics
cancer
inflammatory disease
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Fierce Biotech
Tue, 08/15/23 - 11:41 am
Tentarix Biotherapeutics
Gilead Sciences
oncology
inflammatory disease
Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions
Benzinga
Wed, 12/7/22 - 09:42 am
Paragon Therapeutics
Apogee Therapeutics
APG777
inflammatory disease
MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimab
Pharmaforum
Tue, 05/4/21 - 10:37 am
MoonLake Immunotherapeutics
sonelokimab
Merck KGaA
inflammatory disease
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Thu, 02/18/21 - 10:05 pm
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field
Fierce Biotech
Mon, 09/21/20 - 10:28 am
Roche
M&A
Inflazome
inflammatory disease
J&J collaborates with Aldeyra on new drugs for systemic inflammatory diseases
Endpoints
Tue, 02/27/18 - 09:49 am
JNJ
Aldeyra Therapeutics
inflammatory disease
R&D
Express Scripts targets inflammatory diseases for latest cost control program
Bizjournals.com
Thu, 09/8/16 - 09:52 am
Express Scripts
PBMs
inflammatory disease
drug pricing
Novo Nordisk to exit inflammatory disease research
Pharmaphorum
Tue, 09/2/14 - 08:07 am
Novo Nordisk
R&D
inflammatory disease
NN8226